Browse by Audience
Skip to content
Papers of the Week
Pituitary cyclase-activating polypeptide targeted treatments for the treatment of primary headache disorders.
Authors
Karsan N, Edvinsson L, Vecsei L, Goadsby PJAbstract
Migraine is a complex and disabling neurological disorder. Recent years have witnessed the development and emergence of novel treatments for the condition, namely those targeting calcitonin gene-related peptide (CGRP). However, there remains a substantial need for further treatments for those unresponsive to current therapies. Targeting pituitary adenylate cyclase-activating polypeptide (PACAP) as a possible therapeutic strategy in the primary headache disorders has gained interest over recent years.